What are alternative antihypertensive medications to olmesartan 20 mg?

Alternative Antihypertensive Medications to Olmesartan 20mg

For patients requiring an alternative to olmesartan 20mg, switch to another angiotensin receptor blocker (ARB) at equivalent dosing, or if ARBs are contraindicated, use an ACE inhibitor as the preferred alternative. 1

ARB Alternatives (First Choice)

If switching due to side effects other than angioedema, other ARBs are the most direct alternatives and include:

• Candesartan 8-16 mg once daily (target 32 mg) 2, 1
• Losartan 50 mg once daily (target 100 mg) 1
• Valsartan 80-160 mg once daily (target 320 mg) 1
• Irbesartan 150 mg once daily (target 300 mg) 1
• Telmisartan 40 mg once daily (target 80 mg) 1
• Azilsartan 40 mg once daily (target 80 mg) 1

Important caveat: If the patient developed angioedema with olmesartan, ARBs should be used with extreme caution. While angioedema is much less frequent with ARBs than ACE inhibitors, cross-reactivity can occur. If an ARB must be used after olmesartan-associated angioedema, wait at least 6 weeks and monitor closely. 3, 4

ACE Inhibitor Alternatives (Second Choice)

If ARBs are not tolerated or contraindicated, ACE inhibitors are the preferred alternative as they similarly block the renin-angiotensin system:

• Lisinopril 10 mg once daily (target 20-40 mg) 1, 5
• Ramipril 2.5-5 mg once daily (target 10 mg) 1, 5
• Enalapril 5 mg twice daily (target 10-20 mg twice daily) 1, 5
• Perindopril 4 mg once daily (target 8-16 mg) 1

Critical warning: Never use ACE inhibitors in patients with a history of angioedema from any cause. ACE inhibitor-induced cough occurs in up to 20% of patients and is more common in certain populations (particularly Chinese patients at ~50%). 3, 5

Other First-Line Alternatives

According to the 2017 ACC/AHA guidelines, if renin-angiotensin system blockade is not required or tolerated, calcium channel blockers (CCBs) and thiazide-like diuretics are equally effective first-line alternatives: 1, 6

Calcium Channel Blockers:

• Amlodipine 5 mg once daily (target 10 mg) - preferred dihydropyridine 1
• Chlorthalidone 12.5 mg once daily (target 25 mg) - preferred over hydrochlorothiazide for superior cardiovascular outcomes 1, 7

Clinical Decision Algorithm

Choose based on these specific scenarios:

1. Side effects (not angioedema): Switch to another ARB at equivalent dose
2. Angioedema with olmesartan: Avoid all ARBs; use CCB or thiazide-like diuretic instead
3. Persistent cough concern: Use ARB rather than ACE inhibitor
4. Heart failure with reduced ejection fraction: Prefer candesartan, losartan, or valsartan (proven mortality benefit) 3, 2, 5
5. Post-myocardial infarction: ACE inhibitors or ARBs with proven benefit 8
6. Chronic kidney disease/diabetes: ACE inhibitor or ARB required for renal protection 9
7. Black patients: May have reduced response to ARBs/ACE inhibitors alone; consider adding CCB or thiazide 1, 10

Dosing Equivalency

Olmesartan 20 mg is roughly equivalent to:

• Losartan 50 mg (though olmesartan shows superior BP reduction in head-to-head trials) 11, 12
• Valsartan 80 mg 11
• Irbesartan 150 mg 11
• Candesartan 8 mg 11

Common Pitfalls to Avoid

• Do not combine ACE inhibitors with ARBs - increases risk of hyperkalemia, hypotension, and renal dysfunction without additional benefit 3, 1, 5
• Monitor renal function and potassium within 1-2 weeks of switching to any renin-angiotensin system blocker 5
• Avoid in pregnancy - all ARBs and ACE inhibitors are contraindicated 1, 4
• Check for bilateral renal artery stenosis - can cause acute renal failure with ARBs/ACE inhibitors 1